Viking Therapeutics to start obesity drug mid-stage trial
(Reuters) – Viking Therapeutics Inc said on Tuesday it will begin testing its experimental obesity drug in a mid-stage trial after reporting promising early-stage data. The drug candidate, VK2735, showed up to 6% reduction in mean weight compared to placebo in a small early-stage trial, the company said in a statement. Viking also said the drug was safe and well-tolerated, with majority of adverse events being mild or moderate in […]